Optimising RAASi Management in Cardiorenal Patients: An Expert Roundtable

Published: 23 April 2024

  • Views:

    Views Icon 8921

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

In this on-demand version of the live roundtable, cardiologists Dr Shelley Zieroth (University of Manitoba, Winnipeg, CA) and Dr Aaron Wong (Princess of Wales Hospital, Wales, UK) join nephrologists Dr Andrew Frankel (Imperial College Healthcare NHS Trust, London, UK), and Dr Manish Sood (University of Ottawa, CA) to discuss the nuanced landscape of RAASi management in cardiorenal patients.

 

In this discussion, our expert faculty consider approaches to optimal RAASi dosing and strategies to improve patient outcomes. The programme integrates data-driven insights, established guidelines, and expert consensus, offering participants a holistic understanding of RAASi management.

 

A case study highlights how to overcome barriers to optimal guideline-directed medical therapy and panel discussion will bridge theory and real-world application, providing you with actionable tools to implement optimal practices in your daily clinical pursuits.

This programme is supported by an unrestricted educational grant from AstraZeneca.

Learning Objectives

  • Describe the prevalence and clinical impact of sub-optimal RAASi use in cardiorenal patients
  • Recall key messages from current guidelines, consensus and clinical evidence for optimised RAASi management in cardiorenal patients
  • Describe common barriers to optimise RAASi management strategies
  • Use expert-led guidance to develop a practical approach to overcoming the barriers to RAASi use and the reinitiation/up-titration of therapy

Target Audience

  • Cardiologists
  • Heart Failure Specialists
  • Nephrologists
  • Other Allied HCPs

More from this programme

Part 1

RAASi Management in CKD/HF: What We Should Be Doing

3 sessions
Background and Guidelines Watch now
Case Presentation Watch now
Panel Discussion and Q&A Watch now

Part 2

RAASi Management in CKD/HF: What Is Happening in The Real World?

2 sessions
Barriers and Real-world Evidence Watch now
Panel Discussion and Q&A Watch now

Part 3

Key Learnings / Summary

1 session
Key Learnings / Summary Watch now

Faculty Biographies

Andrew Frankel

Andrew Frankel

Consultant Nephrologist

Dr Andrew Frankel has been working as a consultant nephrologist at Imperial College Healthcare NHS trust since 1995. He has experience in managing all aspects of kidney disease but has a particular interest in relation to the management of diabetes in the context of kidney disease. Over the years he has maintained a significant research interest in relation to diabetes and kidney, both in terms of how diabetes affects the kidneys leading to deterioration in kidney function, but also in relation to how the presence of kidney disease influences the management of diabetes.  Because of this experience, Dr Frankel has played a significant role in the development of national guidelines on the management of diabetes in the context of kidney disease. He is a regular speaker both locally and nationally and indeed internationally in relation to matters pertaining to diabetes and the kidney.

In collaboration with colleagues within Imperial College and indeed both…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.